Applera Pledges $75M to Develop Therapeutic, Diagnostic Products | GenomeWeb

NEW YORK, July 24 – Applera said Tuesday that it would spend $75 million over the next year to establish a wide-ranging drug discovery program across its three businesses, Celera Genomics, Celera Diagnostics, and Applied Biosystems.

The initiative would seek to commercialize therapeutic and diagnostic products based on its genomic and SNP data. The three Applera companies would make equal funding contributions to the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.